Company Overview and News

 
McDonald's unloads China business - Business Insider

2017-01-09 businessinsider
A woman walks past a McDonald's outlet in Hong Kong in this July 25, 2014 file photo. REUTERS/Tyrone Siu

 
McDonald's sells most of China, HK business to CITIC, Carlyle for US$2.1 billion

2017-01-09 channelnewsasia
HONG KONG: McDonald's Corp has agreed to sell the bulk of its China and Hong Kong business to state-backed conglomerate CITIC Ltd and Carlyle Group LP for up to US$2.1 billion, seeking to expand rapidly without using much of its own capital.

 
McDonald’s Sells Control of China Business to Citic, Carlyle - Bloomberg

2017-01-09 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
McDonald’s Said to Sign Deal Monday on China Franchise Sale - Bloomberg

2017-01-09 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
McDonald's to keep up to 25 percent stake in China, Hong Kong stores - source

2016-12-06 in.reuters
HONG KONG McDonald's Corp is looking to raise $1 billion to $2 billion with the sale of its China and Hong Kong stores after the U.S. fast-food chain decided to keep "a significant minority stake in the business," a person with direct knowledge of the plans said on Tuesday.

 
McDonald's to keep up to 25% stake in China, HK stores: Source

2016-12-06 channelnewsasia
HONG KONG: McDonald's Corp is looking to raise US$1 billion to US$2 billion with the sale of its China and Hong Kong stores after the US fast-food chain decided to keep "a significant minority stake in the business," a person with direct knowledge of the plans said on Tuesday (Dec 6).

 
McDonald's to keep up to 25% stake in China, HK stores - source

2016-12-06 theedgemarkets
HONG KONG (Dec 6): McDonald's Corp is looking to raise US$1 billion to US$2 billion with the sale of its China and Hong Kong stores after the US fast-food chain decided to keep "a significant minority stake in the business," a person with direct knowledge of the plans said on Tuesday.

 
Exclusive: McDonald's to keep minority stake in China, Hong Kong stores - source

2016-12-06 channelnewsasia
HONG KONG: McDonald's Corp is looking to raise US$1 billion to US$2 billion with the sale of its China and Hong Kong stores after the U.S. fast-food chain decided to keep "a significant minority stake in the business," a person with direct knowledge of the plans said on Tuesday.

 
Carlyle, Bain to battle for McDonald's China assets as TPG pulls out

2016-10-27 reuters
HONG KONG Carlyle Group LP (CG.O) and Bain Capital LLC are the only major global buyout firms left bidding for McDonald's Corp's (MCD.N) restaurants in China and Hong Kong after TPG Capital Management LP [TPG.UL] pulled out, people close to the matter said on Thursday.

 
Carlyle, Bain to battle for McDonald's China assets as TPG pulls out

2016-10-27 channelnewsasia
HONG KONG: Carlyle Group LP and Bain Capital LLC are the only major global buyout firms left bidding for McDonald's Corp's restaurants in China and Hong Kong after TPG Capital Management LP pulled out, people close to the matter said on Thursday.

 
McDonald's Follows Yum Brands, Prepares China Exit

2016-09-19 seekingalpha
McDonald's (NYSE:MCD) is finalizing a sale of the right to operate its China and Hong Kong restaurants. Prompted by stagnating market share and an increasingly challenging operating environment, the move allows McDonald's to keep a presence in China without the burden of ownership.

 
McDonald's Said to Get 3 Final Bids for Its China Restaurants

2016-09-15 fortune
Fast-food giant McDonald’s Corp has received final offers from at least three bidding groups for its China and Hong Kong outlets, with global private equity firms Carlyle Group and TPG Capital teaming up with Chinese partners for the business worth up to $3 billion, sources told Reuters.

 
McDonald's gets final bids for N.Asia outlets -sources

2016-09-15 theedgemarkets
HONG KONG (Sept 15): Fast-food giant McDonald's Corp has received final bids from at least three groups for its China and Hong Kong outlets, with global private equity firms Carlyle Group and TPG Capital separately teaming up with Chinese partners for the business worth up to US$3 billion, sources told Reuters.

 
McDonald's gets final bids for North Asia outlets: sources

2016-09-15 channelnewsasia
HONG KONG: Fast-food giant McDonald's Corp has received final bids from at least three groups for its China and Hong Kong outlets, with global private equity firms Carlyle Group and TPG Capital separately teaming up with Chinese partners for the business worth up to US$3 billion, sources told Reuters.

 
McDonald’s said to get final bids for North Asia stores

2016-09-15 themalaymailonline
Customers stand outside of a McDonald's store in downtown Shanghai July 31, 2014. — Reuters picHONG KONG, Sept 15 — Fast-food giant McDonald's Corp has received final offers from at least three bidding groups for its China and Hong Kong outlets, with global private equity firms Carlyle Group and TPG Capital teaming up with Chinese partners for the business worth up to US$3 billion (RM12.4 billion), sources told Reuters.

Related Articles

SGMO: Sangamo BioSciences and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

BSTG: Biostage Analysis and Research Report

2018-05-17 - Asif

Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...